Kennondale Capital Management LLC Akero Therapeutics, Inc. Transaction History
Kennondale Capital Management LLC
- $89.3 Billion
- Q4 2024
A detailed history of Kennondale Capital Management LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Kennondale Capital Management LLC holds 28,217 shares of AKRO stock, worth $1.25 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
28,217Holding current value
$1.25 Million% of portfolio
0.88%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$326 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$303 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$266 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$247 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$231 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.05B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...